Colchicine promotes antigen cross-presentation by murine dendritic cells [5]

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1543-1546

  Mizumoto, Norikatsu ^a   Tanaka, Hiroaki ^a   Matsushima, Hironori ^a   Vishwanath, Mridula ^a   Takashima, Akira ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; COLCHICINE; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CD4+ T LYMPHOCYTE; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CROSS PRESENTATION; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMORAL IMMUNITY; LANGERHANS CELL; LETTER; LOW DRUG DOSE; MITOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; COLCHICINE; DENDRITIC CELLS; HUMANS; MICE; MICE, INBRED BALB C; TUBULIN MODULATORS;

EID: 34248587497     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700699     Document Type: Letter

References (15)

1. Ackerman AL, Cresswell P (2004) Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 5:678-84
2. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188:1359-68
3. Bibas R, Gaspar NK, Ramos-e-Silva M (2005) Colchicine for dermatologic diseases. J Drugs Dermatol 4:196-204
4. Blocker A, Severin FF, Burkhardt JK, Bingham JB, Yu H, Olivo JC et al. (1997) Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol 137:113-29
5. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G (1995) Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 96:994-1002
6. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199:9-26
7. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-5
8. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253-65
9. Keller HU, Naef A, Zimmermann A (1984) Effects of colchicine, vinblastine and nocodazole on polarity, motility, chemotaxis and cAMP levels of human polymorphonuclear leukocytes. Exp Cell Res 153:173-85
10. Mizumoto N, Gao J, Matsushima H, Ogawa Y, Tanaka H, Takashima A (2005) Discovery of novel immunostimulants by dendritic cell-based functional screening. Blood 106:3082-9
11. Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J Exp Med 182:389-400
12. Sigal LJ, Crotty S, Andino R, Rock KL (1999) Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398:77-80
13. Sullivan TP, King LE Jr, Boyd AS (1998) Colchicine in dermatology. J Am Acad Dermatol 39:993-9
14. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975-1028
15. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG et al. (2004) Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305:1153-7